Skip to content

North Carolina unified in attracting new ARPA-H headquarters to the state

Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.

NCBIO Roadmap to Diversity Event

“Our workforces are more dynamic. They're more empowered, they're more enlightened, and they want answers not just from the standpoint of their functional skills and capabilities in our business performance. But also what is it that our company stands for?” -- Keynote speaker Celeste Warren, VP, Merck Global Diversity and Inclusion Center

IP rights are at the heart of innovation and investment

In June, the World Trade Organization agreed to waive IP protections for COVID-19 vaccines, a decision supported by the Biden administration. The WTO is now considering expanding the waiver to include COVID-19 therapeutics and diagnostics.

Bio Business Solutions

NCBIO Members Save Big with BIO Business Solutions

BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.

Bio Business Solutions

NCBIO, the North Carolina Biosciences Organization

NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.

Member Benefits

A variety of discount programs are available to members.

Where things stand with the TRIPS waiver

November 2, 2022

The World Trade Organization is considering continuing to waive certain intellectual property rights on COVID-19 diagnostics and therapeutics, following a recent decision to do the same for vaccines.

Read More

Expanding COVID IP waiver would harm small, medium enterprises, CSBA says

October 28, 2022

Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology.

Read More

Part D drug price “negotiation” comes at cost of jobs, investment, cures 

August 11, 2022

Congress passed the Inflation Reduction Act on Aug. 12. Included in the law is a provision that gives Medicare Part D the ability to “negotiate” the price of medicines for the first time. Negotiate is in quotation marks because lawmakers are being ironic; no one can legitimately call the new price-setting policy a negotiation.

Read More

BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy

April 8, 2022

On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the…

Read More

2022 Annual Meeting discusses workforce, health equity, investment, locating in NC 

November 2, 2022

The 2022 NCBIO Annual Meeting held Oct. 12 at the NC Biotechnology Center featured expert panels on locating in North Carolina, talent recruitment, financial trends and health equity and disparities. The meeting returned to being fully in person this year after several years of being virtual or offering an online option due to the COVID pandemic.

Read More

2022 NCBIO Year in Review

October 27, 2022

In this past year, we emerged from the isolation of COVID-19 thanks in no small part to the heroic work of the life sciences industry in developing vaccines, rapid tests and new treatments that have made the pandemic much more manageable. In spite of this success, we have faced tremendous pressure at the federal level with threats to intellectual property, the lifeblood of the industry, and a push to insert price controls with potential repercussions on innovation.

Read More

Burr shares insights from 28-year Congressional career

October 24, 2022

Sen. Richard Burr reflected on his 28-year career in Congress and discussed FDA reform, the nation’s response to future pandemics and the pitfalls of the nation’s regulatory system at the 2022 NCBIO Annual Dinner held Monday, Oct. 10, at the NC Biotechnology Center.

Read More

Workforce and talent development topics of discussion at September BMF meeting  

September 20, 2022

At their quarterly meeting held Wednesday, Sept. 14, members of the NCBIO Biomanufacturers Forum learned about efforts and options for bolstering workforce and talent development in North Carolina. Members also received an update on the $25 million Build Back Better awarded to expand, connect and promote training and career opportunities in North Carolina.

Read More

Sustaining Members

Novo Nordisk logo
Pfizer logo

Supporting Members